NCT03179891 - Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 25, 2017

Primary Completion Date

July 25, 2018

Study Completion Date

December 21, 2018

Conditions

Epilepsy

Interventions

DRUG

Diazepam Buccal Film 12.5 mg

All subjects received a single dose of DBF 12.5 mg during the interictal state and during the ictal/peri-ictal state with at least 14 days washout between the 2 treatment periods

Trial Locations (11)

14642

University of Rochester Medical Center, Rochester

19104

Hospital of the University of Pennsylvania, Philadelphia

20817

Mid-Atlantic Epilepsy and Sleep Center, Bethesda

23219

Virginia Commonwealth University Medical Center, Richmond

28203

Onsite Clinical Solutions LLC, Charlotte

78758

Austin Epilepsy Care Center, Austin

90242

Rancho Research Institute, Downey

96817

Hawaii Pacific Neuroscience, Honolulu

85724-5023

Arizona Health Sciences Center, Tucson

06520-8018

Yale University School of Medicine-Comprehensive Epilepsy Center, New Haven

08901

Saint Peter's University Hospital, New Brunswick